nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—NTRK1—Sunitinib—pancreatic cancer	0.0844	0.212	CbGbCtD
Amitriptyline—Cyclobenzaprine—Tamoxifen—pancreatic cancer	0.0599	0.15	CrCrCtD
Amitriptyline—Doxylamine—Tamoxifen—pancreatic cancer	0.055	0.138	CrCrCtD
Amitriptyline—Tripelennamine—Tamoxifen—pancreatic cancer	0.0498	0.125	CrCrCtD
Amitriptyline—Dimetacrine—Tamoxifen—pancreatic cancer	0.0465	0.116	CrCrCtD
Amitriptyline—Bromodiphenhydramine—Tamoxifen—pancreatic cancer	0.0465	0.116	CrCrCtD
Amitriptyline—SIGMAR1—Tamoxifen—pancreatic cancer	0.0444	0.112	CbGbCtD
Amitriptyline—Clofedanol—Tamoxifen—pancreatic cancer	0.0378	0.0946	CrCrCtD
Amitriptyline—Orphenadrine—Tamoxifen—pancreatic cancer	0.0366	0.0915	CrCrCtD
Amitriptyline—Promazine—Tamoxifen—pancreatic cancer	0.0349	0.0873	CrCrCtD
Amitriptyline—Diphenhydramine—Tamoxifen—pancreatic cancer	0.0325	0.0813	CrCrCtD
Amitriptyline—ORM1—Erlotinib—pancreatic cancer	0.0238	0.0597	CbGbCtD
Amitriptyline—CYP2E1—Dacarbazine—pancreatic cancer	0.0153	0.0384	CbGbCtD
Amitriptyline—CYP2E1—Tamoxifen—pancreatic cancer	0.0122	0.0306	CbGbCtD
Amitriptyline—CYP2B6—Tamoxifen—pancreatic cancer	0.012	0.0302	CbGbCtD
Amitriptyline—ALB—Erlotinib—pancreatic cancer	0.01	0.0251	CbGbCtD
Amitriptyline—CYP3A5—Tamoxifen—pancreatic cancer	0.00946	0.0238	CbGbCtD
Amitriptyline—CYP2B6—Irinotecan—pancreatic cancer	0.00922	0.0232	CbGbCtD
Amitriptyline—CYP2C8—Tamoxifen—pancreatic cancer	0.0091	0.0228	CbGbCtD
Amitriptyline—ALB—Irinotecan—pancreatic cancer	0.00904	0.0227	CbGbCtD
Amitriptyline—CYP1A2—Dacarbazine—pancreatic cancer	0.00885	0.0222	CbGbCtD
Amitriptyline—ALB—Fluorouracil—pancreatic cancer	0.00868	0.0218	CbGbCtD
Amitriptyline—HRH2—gastric juice—pancreatic cancer	0.0082	0.297	CbGeAlD
Amitriptyline—CYP3A5—Erlotinib—pancreatic cancer	0.00805	0.0202	CbGbCtD
Amitriptyline—CYP2C8—Erlotinib—pancreatic cancer	0.00774	0.0194	CbGbCtD
Amitriptyline—CYP2C19—Tamoxifen—pancreatic cancer	0.00763	0.0192	CbGbCtD
Amitriptyline—CYP3A5—Irinotecan—pancreatic cancer	0.00727	0.0182	CbGbCtD
Amitriptyline—CYP1A2—Tamoxifen—pancreatic cancer	0.00704	0.0177	CbGbCtD
Amitriptyline—CYP2C8—Fluorouracil—pancreatic cancer	0.0067	0.0168	CbGbCtD
Amitriptyline—CYP2C9—Tamoxifen—pancreatic cancer	0.00635	0.0159	CbGbCtD
Amitriptyline—ABCB1—Tamoxifen—pancreatic cancer	0.00616	0.0155	CbGbCtD
Amitriptyline—CYP1A2—Erlotinib—pancreatic cancer	0.00599	0.015	CbGbCtD
Amitriptyline—CYP2D6—Tamoxifen—pancreatic cancer	0.0058	0.0146	CbGbCtD
Amitriptyline—CYP3A5—Docetaxel—pancreatic cancer	0.00532	0.0134	CbGbCtD
Amitriptyline—ABCB1—Gemcitabine—pancreatic cancer	0.00531	0.0133	CbGbCtD
Amitriptyline—CYP3A5—Sunitinib—pancreatic cancer	0.0053	0.0133	CbGbCtD
Amitriptyline—ABCB1—Erlotinib—pancreatic cancer	0.00524	0.0131	CbGbCtD
Amitriptyline—CYP1A2—Fluorouracil—pancreatic cancer	0.00519	0.013	CbGbCtD
Amitriptyline—CYP2B6—Doxorubicin—pancreatic cancer	0.00504	0.0127	CbGbCtD
Amitriptyline—CYP2D6—Erlotinib—pancreatic cancer	0.00493	0.0124	CbGbCtD
Amitriptyline—ABCB1—Irinotecan—pancreatic cancer	0.00473	0.0119	CbGbCtD
Amitriptyline—CYP2C9—Fluorouracil—pancreatic cancer	0.00468	0.0117	CbGbCtD
Amitriptyline—HTR7—enteric nervous system—pancreatic cancer	0.00443	0.16	CbGeAlD
Amitriptyline—CYP3A4—Tamoxifen—pancreatic cancer	0.00369	0.00926	CbGbCtD
Amitriptyline—ABCB1—Docetaxel—pancreatic cancer	0.00347	0.0087	CbGbCtD
Amitriptyline—ABCB1—Sunitinib—pancreatic cancer	0.00345	0.00866	CbGbCtD
Amitriptyline—ORM1—bile—pancreatic cancer	0.00322	0.117	CbGeAlD
Amitriptyline—CYP3A4—Erlotinib—pancreatic cancer	0.00314	0.00788	CbGbCtD
Amitriptyline—CYP3A4—Irinotecan—pancreatic cancer	0.00283	0.00711	CbGbCtD
Amitriptyline—HTR2A—enteric nervous system—pancreatic cancer	0.00276	0.1	CbGeAlD
Amitriptyline—ABCB1—Doxorubicin—pancreatic cancer	0.00258	0.00649	CbGbCtD
Amitriptyline—CYP2D6—Doxorubicin—pancreatic cancer	0.00243	0.00611	CbGbCtD
Amitriptyline—CYP3A4—Docetaxel—pancreatic cancer	0.00208	0.00521	CbGbCtD
Amitriptyline—CYP3A4—Sunitinib—pancreatic cancer	0.00207	0.00519	CbGbCtD
Amitriptyline—CYP3A4—Doxorubicin—pancreatic cancer	0.00155	0.00389	CbGbCtD
Amitriptyline—KCND3—islet of Langerhans—pancreatic cancer	0.00107	0.0387	CbGeAlD
Amitriptyline—ORM1—gall bladder—pancreatic cancer	0.000893	0.0324	CbGeAlD
Amitriptyline—ALB—gall bladder—pancreatic cancer	0.000783	0.0284	CbGeAlD
Amitriptyline—KCND3—pancreas—pancreatic cancer	0.000751	0.0272	CbGeAlD
Amitriptyline—HRH2—digestive system—pancreatic cancer	0.0005	0.0181	CbGeAlD
Amitriptyline—SIGMAR1—islet of Langerhans—pancreatic cancer	0.000495	0.0179	CbGeAlD
Amitriptyline—SIGMAR1—pancreas—pancreatic cancer	0.000348	0.0126	CbGeAlD
Amitriptyline—CYP3A5—islet of Langerhans—pancreatic cancer	0.000326	0.0118	CbGeAlD
Amitriptyline—ADRA2A—islet of Langerhans—pancreatic cancer	0.00031	0.0112	CbGeAlD
Amitriptyline—SLC6A4—digestive system—pancreatic cancer	0.0003	0.0109	CbGeAlD
Amitriptyline—CHRM3—digestive system—pancreatic cancer	0.000267	0.00967	CbGeAlD
Amitriptyline—HTR7—digestive system—pancreatic cancer	0.000254	0.00921	CbGeAlD
Amitriptyline—CYP2C19—digestive system—pancreatic cancer	0.000248	0.00899	CbGeAlD
Amitriptyline—CYP3A5—pancreas—pancreatic cancer	0.000229	0.00829	CbGeAlD
Amitriptyline—ADRA2A—pancreas—pancreatic cancer	0.000218	0.00791	CbGeAlD
Amitriptyline—CYP1A2—digestive system—pancreatic cancer	0.000203	0.00734	CbGeAlD
Amitriptyline—CYP3A5—digestive system—pancreatic cancer	0.000196	0.00708	CbGeAlD
Amitriptyline—CYP2B6—digestive system—pancreatic cancer	0.000194	0.00704	CbGeAlD
Amitriptyline—CYP2C9—digestive system—pancreatic cancer	0.000192	0.00697	CbGeAlD
Amitriptyline—HRH1—digestive system—pancreatic cancer	0.00019	0.00687	CbGeAlD
Amitriptyline—CYP2E1—digestive system—pancreatic cancer	0.000182	0.00661	CbGeAlD
Amitriptyline—ABCB1—islet of Langerhans—pancreatic cancer	0.000173	0.00627	CbGeAlD
Amitriptyline—HTR2A—digestive system—pancreatic cancer	0.000158	0.00574	CbGeAlD
Amitriptyline—CYP3A4—digestive system—pancreatic cancer	0.000147	0.00532	CbGeAlD
Amitriptyline—CYP2D6—digestive system—pancreatic cancer	0.000144	0.00523	CbGeAlD
Amitriptyline—Pruritus—Erlotinib—pancreatic cancer	0.000143	0.00212	CcSEcCtD
Amitriptyline—Discomfort—Fluorouracil—pancreatic cancer	0.000142	0.00211	CcSEcCtD
Amitriptyline—Purpura—Epirubicin—pancreatic cancer	0.000142	0.00211	CcSEcCtD
Amitriptyline—Shock—Irinotecan—pancreatic cancer	0.000142	0.00211	CcSEcCtD
Amitriptyline—Vascular purpura—Doxorubicin—pancreatic cancer	0.000141	0.0021	CcSEcCtD
Amitriptyline—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000141	0.0021	CcSEcCtD
Amitriptyline—Hepatic failure—Doxorubicin—pancreatic cancer	0.000141	0.00209	CcSEcCtD
Amitriptyline—Oedema—Gemcitabine—pancreatic cancer	0.00014	0.00209	CcSEcCtD
Amitriptyline—Hepatitis—Docetaxel—pancreatic cancer	0.00014	0.00208	CcSEcCtD
Amitriptyline—Diarrhoea—Tamoxifen—pancreatic cancer	0.00014	0.00208	CcSEcCtD
Amitriptyline—Hypoaesthesia—Docetaxel—pancreatic cancer	0.000139	0.00207	CcSEcCtD
Amitriptyline—Cerebrovascular accident—Epirubicin—pancreatic cancer	0.000139	0.00207	CcSEcCtD
Amitriptyline—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000139	0.00207	CcSEcCtD
Amitriptyline—Confusional state—Fluorouracil—pancreatic cancer	0.000139	0.00207	CcSEcCtD
Amitriptyline—Body temperature increased—Sunitinib—pancreatic cancer	0.000138	0.00205	CcSEcCtD
Amitriptyline—Diarrhoea—Erlotinib—pancreatic cancer	0.000138	0.00205	CcSEcCtD
Amitriptyline—Oedema—Fluorouracil—pancreatic cancer	0.000138	0.00205	CcSEcCtD
Amitriptyline—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000137	0.00204	CcSEcCtD
Amitriptyline—Anorexia—Irinotecan—pancreatic cancer	0.000137	0.00204	CcSEcCtD
Amitriptyline—Osteoarthritis—Epirubicin—pancreatic cancer	0.000137	0.00203	CcSEcCtD
Amitriptyline—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000136	0.00202	CcSEcCtD
Amitriptyline—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000135	0.00201	CcSEcCtD
Amitriptyline—Dizziness—Tamoxifen—pancreatic cancer	0.000135	0.00201	CcSEcCtD
Amitriptyline—Tachycardia—Fluorouracil—pancreatic cancer	0.000135	0.002	CcSEcCtD
Amitriptyline—Hypotension—Irinotecan—pancreatic cancer	0.000135	0.002	CcSEcCtD
Amitriptyline—Anorexia—Gemcitabine—pancreatic cancer	0.000134	0.00199	CcSEcCtD
Amitriptyline—Dizziness—Erlotinib—pancreatic cancer	0.000134	0.00199	CcSEcCtD
Amitriptyline—Anorexia—Fluorouracil—pancreatic cancer	0.000131	0.00195	CcSEcCtD
Amitriptyline—Purpura—Doxorubicin—pancreatic cancer	0.000131	0.00195	CcSEcCtD
Amitriptyline—Hypotension—Gemcitabine—pancreatic cancer	0.000131	0.00195	CcSEcCtD
Amitriptyline—Insomnia—Irinotecan—pancreatic cancer	0.00013	0.00194	CcSEcCtD
Amitriptyline—Vomiting—Tamoxifen—pancreatic cancer	0.00013	0.00193	CcSEcCtD
Amitriptyline—Paraesthesia—Irinotecan—pancreatic cancer	0.000129	0.00192	CcSEcCtD
Amitriptyline—Cerebrovascular accident—Doxorubicin—pancreatic cancer	0.000129	0.00192	CcSEcCtD
Amitriptyline—Hypotension—Fluorouracil—pancreatic cancer	0.000129	0.00192	CcSEcCtD
Amitriptyline—Rash—Tamoxifen—pancreatic cancer	0.000129	0.00191	CcSEcCtD
Amitriptyline—Dermatitis—Tamoxifen—pancreatic cancer	0.000129	0.00191	CcSEcCtD
Amitriptyline—Ataxia—Epirubicin—pancreatic cancer	0.000128	0.00191	CcSEcCtD
Amitriptyline—Vomiting—Erlotinib—pancreatic cancer	0.000128	0.00191	CcSEcCtD
Amitriptyline—Somnolence—Irinotecan—pancreatic cancer	0.000128	0.0019	CcSEcCtD
Amitriptyline—Headache—Tamoxifen—pancreatic cancer	0.000128	0.0019	CcSEcCtD
Amitriptyline—Rash—Erlotinib—pancreatic cancer	0.000127	0.00189	CcSEcCtD
Amitriptyline—Dermatitis—Erlotinib—pancreatic cancer	0.000127	0.00189	CcSEcCtD
Amitriptyline—Insomnia—Gemcitabine—pancreatic cancer	0.000127	0.00189	CcSEcCtD
Amitriptyline—Dyspepsia—Irinotecan—pancreatic cancer	0.000127	0.00188	CcSEcCtD
Amitriptyline—Headache—Erlotinib—pancreatic cancer	0.000127	0.00188	CcSEcCtD
Amitriptyline—Osteoarthritis—Doxorubicin—pancreatic cancer	0.000126	0.00188	CcSEcCtD
Amitriptyline—Paraesthesia—Gemcitabine—pancreatic cancer	0.000126	0.00187	CcSEcCtD
Amitriptyline—Asthenia—Sunitinib—pancreatic cancer	0.000125	0.00186	CcSEcCtD
Amitriptyline—Decreased appetite—Irinotecan—pancreatic cancer	0.000125	0.00186	CcSEcCtD
Amitriptyline—Arrhythmia—Docetaxel—pancreatic cancer	0.000125	0.00186	CcSEcCtD
Amitriptyline—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000125	0.00185	CcSEcCtD
Amitriptyline—Insomnia—Fluorouracil—pancreatic cancer	0.000125	0.00185	CcSEcCtD
Amitriptyline—Somnolence—Gemcitabine—pancreatic cancer	0.000125	0.00185	CcSEcCtD
Amitriptyline—Fatigue—Irinotecan—pancreatic cancer	0.000124	0.00185	CcSEcCtD
Amitriptyline—Paraesthesia—Fluorouracil—pancreatic cancer	0.000124	0.00184	CcSEcCtD
Amitriptyline—Alopecia—Docetaxel—pancreatic cancer	0.000124	0.00184	CcSEcCtD
Amitriptyline—Pruritus—Sunitinib—pancreatic cancer	0.000124	0.00184	CcSEcCtD
Amitriptyline—Constipation—Irinotecan—pancreatic cancer	0.000123	0.00183	CcSEcCtD
Amitriptyline—Somnolence—Fluorouracil—pancreatic cancer	0.000123	0.00182	CcSEcCtD
Amitriptyline—Decreased appetite—Gemcitabine—pancreatic cancer	0.000122	0.00181	CcSEcCtD
Amitriptyline—ABCB1—pancreas—pancreatic cancer	0.000122	0.00441	CbGeAlD
Amitriptyline—Dyspepsia—Fluorouracil—pancreatic cancer	0.000121	0.0018	CcSEcCtD
Amitriptyline—Nausea—Tamoxifen—pancreatic cancer	0.000121	0.0018	CcSEcCtD
Amitriptyline—Fatigue—Gemcitabine—pancreatic cancer	0.000121	0.0018	CcSEcCtD
Amitriptyline—Constipation—Gemcitabine—pancreatic cancer	0.00012	0.00178	CcSEcCtD
Amitriptyline—Nausea—Erlotinib—pancreatic cancer	0.00012	0.00178	CcSEcCtD
Amitriptyline—Decreased appetite—Fluorouracil—pancreatic cancer	0.00012	0.00178	CcSEcCtD
Amitriptyline—Diarrhoea—Sunitinib—pancreatic cancer	0.00012	0.00178	CcSEcCtD
Amitriptyline—Dysgeusia—Docetaxel—pancreatic cancer	0.000119	0.00178	CcSEcCtD
Amitriptyline—Ataxia—Doxorubicin—pancreatic cancer	0.000119	0.00177	CcSEcCtD
Amitriptyline—Feeling abnormal—Irinotecan—pancreatic cancer	0.000119	0.00176	CcSEcCtD
Amitriptyline—Eosinophilia—Epirubicin—pancreatic cancer	0.000117	0.00174	CcSEcCtD
Amitriptyline—Dizziness—Sunitinib—pancreatic cancer	0.000116	0.00172	CcSEcCtD
Amitriptyline—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000116	0.00172	CcSEcCtD
Amitriptyline—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000115	0.00172	CcSEcCtD
Amitriptyline—Body temperature increased—Irinotecan—pancreatic cancer	0.000114	0.00169	CcSEcCtD
Amitriptyline—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000114	0.00169	CcSEcCtD
Amitriptyline—Pancytopenia—Epirubicin—pancreatic cancer	0.000112	0.00167	CcSEcCtD
Amitriptyline—Vomiting—Sunitinib—pancreatic cancer	0.000111	0.00165	CcSEcCtD
Amitriptyline—Body temperature increased—Gemcitabine—pancreatic cancer	0.000111	0.00165	CcSEcCtD
Amitriptyline—Rash—Sunitinib—pancreatic cancer	0.00011	0.00164	CcSEcCtD
Amitriptyline—Dermatitis—Sunitinib—pancreatic cancer	0.00011	0.00164	CcSEcCtD
Amitriptyline—Urticaria—Fluorouracil—pancreatic cancer	0.00011	0.00163	CcSEcCtD
Amitriptyline—Headache—Sunitinib—pancreatic cancer	0.00011	0.00163	CcSEcCtD
Amitriptyline—Syncope—Docetaxel—pancreatic cancer	0.000109	0.00163	CcSEcCtD
Amitriptyline—Leukopenia—Docetaxel—pancreatic cancer	0.000109	0.00162	CcSEcCtD
Amitriptyline—Pollakiuria—Epirubicin—pancreatic cancer	0.000109	0.00162	CcSEcCtD
Amitriptyline—Body temperature increased—Fluorouracil—pancreatic cancer	0.000109	0.00162	CcSEcCtD
Amitriptyline—Eosinophilia—Doxorubicin—pancreatic cancer	0.000108	0.00161	CcSEcCtD
Amitriptyline—Palpitations—Docetaxel—pancreatic cancer	0.000108	0.0016	CcSEcCtD
Amitriptyline—Weight increased—Epirubicin—pancreatic cancer	0.000107	0.0016	CcSEcCtD
Amitriptyline—Loss of consciousness—Docetaxel—pancreatic cancer	0.000107	0.00159	CcSEcCtD
Amitriptyline—Convulsion—Docetaxel—pancreatic cancer	0.000106	0.00157	CcSEcCtD
Amitriptyline—Hypertension—Docetaxel—pancreatic cancer	0.000105	0.00157	CcSEcCtD
Amitriptyline—Drowsiness—Epirubicin—pancreatic cancer	0.000105	0.00157	CcSEcCtD
Amitriptyline—ABCB1—digestive system—pancreatic cancer	0.000104	0.00376	CbGeAlD
Amitriptyline—Nausea—Sunitinib—pancreatic cancer	0.000104	0.00154	CcSEcCtD
Amitriptyline—Pancytopenia—Doxorubicin—pancreatic cancer	0.000104	0.00154	CcSEcCtD
Amitriptyline—Asthenia—Irinotecan—pancreatic cancer	0.000103	0.00154	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000103	0.00153	CcSEcCtD
Amitriptyline—Stomatitis—Epirubicin—pancreatic cancer	0.000103	0.00153	CcSEcCtD
Amitriptyline—Jaundice—Epirubicin—pancreatic cancer	0.000103	0.00153	CcSEcCtD
Amitriptyline—Dry mouth—Docetaxel—pancreatic cancer	0.000102	0.00151	CcSEcCtD
Amitriptyline—Pollakiuria—Doxorubicin—pancreatic cancer	0.000101	0.0015	CcSEcCtD
Amitriptyline—Asthenia—Gemcitabine—pancreatic cancer	0.000101	0.0015	CcSEcCtD
Amitriptyline—Confusional state—Docetaxel—pancreatic cancer	0.0001	0.00149	CcSEcCtD
Amitriptyline—Oedema—Docetaxel—pancreatic cancer	9.96e-05	0.00148	CcSEcCtD
Amitriptyline—Weight increased—Doxorubicin—pancreatic cancer	9.94e-05	0.00148	CcSEcCtD
Amitriptyline—Pruritus—Gemcitabine—pancreatic cancer	9.93e-05	0.00148	CcSEcCtD
Amitriptyline—Diarrhoea—Irinotecan—pancreatic cancer	9.85e-05	0.00146	CcSEcCtD
Amitriptyline—Agranulocytosis—Epirubicin—pancreatic cancer	9.83e-05	0.00146	CcSEcCtD
Amitriptyline—Shock—Docetaxel—pancreatic cancer	9.79e-05	0.00146	CcSEcCtD
Amitriptyline—Pruritus—Fluorouracil—pancreatic cancer	9.76e-05	0.00145	CcSEcCtD
Amitriptyline—Thrombocytopenia—Docetaxel—pancreatic cancer	9.75e-05	0.00145	CcSEcCtD
Amitriptyline—Drowsiness—Doxorubicin—pancreatic cancer	9.74e-05	0.00145	CcSEcCtD
Amitriptyline—Tachycardia—Docetaxel—pancreatic cancer	9.72e-05	0.00144	CcSEcCtD
Amitriptyline—Diarrhoea—Gemcitabine—pancreatic cancer	9.6e-05	0.00143	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Doxorubicin—pancreatic cancer	9.55e-05	0.00142	CcSEcCtD
Amitriptyline—Dizziness—Irinotecan—pancreatic cancer	9.52e-05	0.00142	CcSEcCtD
Amitriptyline—Stomatitis—Doxorubicin—pancreatic cancer	9.5e-05	0.00141	CcSEcCtD
Amitriptyline—Jaundice—Doxorubicin—pancreatic cancer	9.5e-05	0.00141	CcSEcCtD
Amitriptyline—Anorexia—Docetaxel—pancreatic cancer	9.49e-05	0.00141	CcSEcCtD
Amitriptyline—Hepatitis—Epirubicin—pancreatic cancer	9.45e-05	0.00141	CcSEcCtD
Amitriptyline—Diarrhoea—Fluorouracil—pancreatic cancer	9.44e-05	0.0014	CcSEcCtD
Amitriptyline—Hypoaesthesia—Epirubicin—pancreatic cancer	9.4e-05	0.0014	CcSEcCtD
Amitriptyline—Hypotension—Docetaxel—pancreatic cancer	9.3e-05	0.00138	CcSEcCtD
Amitriptyline—Vomiting—Irinotecan—pancreatic cancer	9.16e-05	0.00136	CcSEcCtD
Amitriptyline—Dizziness—Fluorouracil—pancreatic cancer	9.12e-05	0.00136	CcSEcCtD
Amitriptyline—Agranulocytosis—Doxorubicin—pancreatic cancer	9.09e-05	0.00135	CcSEcCtD
Amitriptyline—Rash—Irinotecan—pancreatic cancer	9.08e-05	0.00135	CcSEcCtD
Amitriptyline—Dermatitis—Irinotecan—pancreatic cancer	9.07e-05	0.00135	CcSEcCtD
Amitriptyline—Headache—Irinotecan—pancreatic cancer	9.02e-05	0.00134	CcSEcCtD
Amitriptyline—Insomnia—Docetaxel—pancreatic cancer	9e-05	0.00134	CcSEcCtD
Amitriptyline—Paraesthesia—Docetaxel—pancreatic cancer	8.94e-05	0.00133	CcSEcCtD
Amitriptyline—Vomiting—Gemcitabine—pancreatic cancer	8.92e-05	0.00133	CcSEcCtD
Amitriptyline—Somnolence—Docetaxel—pancreatic cancer	8.85e-05	0.00132	CcSEcCtD
Amitriptyline—Rash—Gemcitabine—pancreatic cancer	8.85e-05	0.00131	CcSEcCtD
Amitriptyline—Dermatitis—Gemcitabine—pancreatic cancer	8.84e-05	0.00131	CcSEcCtD
Amitriptyline—Tinnitus—Epirubicin—pancreatic cancer	8.81e-05	0.00131	CcSEcCtD
Amitriptyline—Headache—Gemcitabine—pancreatic cancer	8.79e-05	0.00131	CcSEcCtD
Amitriptyline—Vomiting—Fluorouracil—pancreatic cancer	8.77e-05	0.0013	CcSEcCtD
Amitriptyline—Dyspepsia—Docetaxel—pancreatic cancer	8.76e-05	0.0013	CcSEcCtD
Amitriptyline—Hepatitis—Doxorubicin—pancreatic cancer	8.75e-05	0.0013	CcSEcCtD
Amitriptyline—Hypoaesthesia—Doxorubicin—pancreatic cancer	8.7e-05	0.00129	CcSEcCtD
Amitriptyline—Rash—Fluorouracil—pancreatic cancer	8.7e-05	0.00129	CcSEcCtD
Amitriptyline—Dermatitis—Fluorouracil—pancreatic cancer	8.69e-05	0.00129	CcSEcCtD
Amitriptyline—Decreased appetite—Docetaxel—pancreatic cancer	8.65e-05	0.00129	CcSEcCtD
Amitriptyline—Headache—Fluorouracil—pancreatic cancer	8.64e-05	0.00128	CcSEcCtD
Amitriptyline—Fatigue—Docetaxel—pancreatic cancer	8.58e-05	0.00128	CcSEcCtD
Amitriptyline—Nausea—Irinotecan—pancreatic cancer	8.55e-05	0.00127	CcSEcCtD
Amitriptyline—Constipation—Docetaxel—pancreatic cancer	8.51e-05	0.00127	CcSEcCtD
Amitriptyline—Arrhythmia—Epirubicin—pancreatic cancer	8.44e-05	0.00126	CcSEcCtD
Amitriptyline—Alopecia—Epirubicin—pancreatic cancer	8.35e-05	0.00124	CcSEcCtD
Amitriptyline—Nausea—Gemcitabine—pancreatic cancer	8.33e-05	0.00124	CcSEcCtD
Amitriptyline—Feeling abnormal—Docetaxel—pancreatic cancer	8.2e-05	0.00122	CcSEcCtD
Amitriptyline—Nausea—Fluorouracil—pancreatic cancer	8.19e-05	0.00122	CcSEcCtD
Amitriptyline—Tinnitus—Doxorubicin—pancreatic cancer	8.15e-05	0.00121	CcSEcCtD
Amitriptyline—Dysgeusia—Epirubicin—pancreatic cancer	8.06e-05	0.0012	CcSEcCtD
Amitriptyline—Body temperature increased—Docetaxel—pancreatic cancer	7.87e-05	0.00117	CcSEcCtD
Amitriptyline—Arrhythmia—Doxorubicin—pancreatic cancer	7.81e-05	0.00116	CcSEcCtD
Amitriptyline—Vision blurred—Epirubicin—pancreatic cancer	7.75e-05	0.00115	CcSEcCtD
Amitriptyline—Alopecia—Doxorubicin—pancreatic cancer	7.73e-05	0.00115	CcSEcCtD
Amitriptyline—Ill-defined disorder—Epirubicin—pancreatic cancer	7.63e-05	0.00113	CcSEcCtD
Amitriptyline—Agitation—Epirubicin—pancreatic cancer	7.56e-05	0.00112	CcSEcCtD
Amitriptyline—Dysgeusia—Doxorubicin—pancreatic cancer	7.46e-05	0.00111	CcSEcCtD
Amitriptyline—Malaise—Epirubicin—pancreatic cancer	7.42e-05	0.0011	CcSEcCtD
Amitriptyline—Syncope—Epirubicin—pancreatic cancer	7.38e-05	0.0011	CcSEcCtD
Amitriptyline—Leukopenia—Epirubicin—pancreatic cancer	7.36e-05	0.00109	CcSEcCtD
Amitriptyline—Palpitations—Epirubicin—pancreatic cancer	7.27e-05	0.00108	CcSEcCtD
Amitriptyline—Loss of consciousness—Epirubicin—pancreatic cancer	7.23e-05	0.00108	CcSEcCtD
Amitriptyline—Vision blurred—Doxorubicin—pancreatic cancer	7.17e-05	0.00107	CcSEcCtD
Amitriptyline—Asthenia—Docetaxel—pancreatic cancer	7.14e-05	0.00106	CcSEcCtD
Amitriptyline—Convulsion—Epirubicin—pancreatic cancer	7.13e-05	0.00106	CcSEcCtD
Amitriptyline—Hypertension—Epirubicin—pancreatic cancer	7.1e-05	0.00106	CcSEcCtD
Amitriptyline—Ill-defined disorder—Doxorubicin—pancreatic cancer	7.06e-05	0.00105	CcSEcCtD
Amitriptyline—Pruritus—Docetaxel—pancreatic cancer	7.04e-05	0.00105	CcSEcCtD
Amitriptyline—Agitation—Doxorubicin—pancreatic cancer	7e-05	0.00104	CcSEcCtD
Amitriptyline—Anxiety—Epirubicin—pancreatic cancer	6.98e-05	0.00104	CcSEcCtD
Amitriptyline—Discomfort—Epirubicin—pancreatic cancer	6.92e-05	0.00103	CcSEcCtD
Amitriptyline—Malaise—Doxorubicin—pancreatic cancer	6.87e-05	0.00102	CcSEcCtD
Amitriptyline—Dry mouth—Epirubicin—pancreatic cancer	6.85e-05	0.00102	CcSEcCtD
Amitriptyline—Syncope—Doxorubicin—pancreatic cancer	6.83e-05	0.00101	CcSEcCtD
Amitriptyline—Leukopenia—Doxorubicin—pancreatic cancer	6.81e-05	0.00101	CcSEcCtD
Amitriptyline—Diarrhoea—Docetaxel—pancreatic cancer	6.81e-05	0.00101	CcSEcCtD
Amitriptyline—Confusional state—Epirubicin—pancreatic cancer	6.77e-05	0.00101	CcSEcCtD
Amitriptyline—Palpitations—Doxorubicin—pancreatic cancer	6.73e-05	0.001	CcSEcCtD
Amitriptyline—Oedema—Epirubicin—pancreatic cancer	6.72e-05	0.000998	CcSEcCtD
Amitriptyline—Loss of consciousness—Doxorubicin—pancreatic cancer	6.69e-05	0.000995	CcSEcCtD
Amitriptyline—Shock—Epirubicin—pancreatic cancer	6.61e-05	0.000982	CcSEcCtD
Amitriptyline—Convulsion—Doxorubicin—pancreatic cancer	6.6e-05	0.000981	CcSEcCtD
Amitriptyline—Dizziness—Docetaxel—pancreatic cancer	6.58e-05	0.000979	CcSEcCtD
Amitriptyline—Thrombocytopenia—Epirubicin—pancreatic cancer	6.57e-05	0.000977	CcSEcCtD
Amitriptyline—Hypertension—Doxorubicin—pancreatic cancer	6.57e-05	0.000977	CcSEcCtD
Amitriptyline—Tachycardia—Epirubicin—pancreatic cancer	6.55e-05	0.000974	CcSEcCtD
Amitriptyline—Hyperhidrosis—Epirubicin—pancreatic cancer	6.49e-05	0.000965	CcSEcCtD
Amitriptyline—Anxiety—Doxorubicin—pancreatic cancer	6.46e-05	0.00096	CcSEcCtD
Amitriptyline—Discomfort—Doxorubicin—pancreatic cancer	6.4e-05	0.000952	CcSEcCtD
Amitriptyline—Anorexia—Epirubicin—pancreatic cancer	6.4e-05	0.000952	CcSEcCtD
Amitriptyline—Dry mouth—Doxorubicin—pancreatic cancer	6.34e-05	0.000942	CcSEcCtD
Amitriptyline—Vomiting—Docetaxel—pancreatic cancer	6.33e-05	0.000941	CcSEcCtD
Amitriptyline—Rash—Docetaxel—pancreatic cancer	6.28e-05	0.000933	CcSEcCtD
Amitriptyline—Hypotension—Epirubicin—pancreatic cancer	6.27e-05	0.000933	CcSEcCtD
Amitriptyline—Dermatitis—Docetaxel—pancreatic cancer	6.27e-05	0.000932	CcSEcCtD
Amitriptyline—Confusional state—Doxorubicin—pancreatic cancer	6.26e-05	0.000931	CcSEcCtD
Amitriptyline—Headache—Docetaxel—pancreatic cancer	6.24e-05	0.000927	CcSEcCtD
Amitriptyline—Oedema—Doxorubicin—pancreatic cancer	6.21e-05	0.000924	CcSEcCtD
Amitriptyline—Shock—Doxorubicin—pancreatic cancer	6.11e-05	0.000909	CcSEcCtD
Amitriptyline—Thrombocytopenia—Doxorubicin—pancreatic cancer	6.08e-05	0.000904	CcSEcCtD
Amitriptyline—Insomnia—Epirubicin—pancreatic cancer	6.07e-05	0.000903	CcSEcCtD
Amitriptyline—Tachycardia—Doxorubicin—pancreatic cancer	6.06e-05	0.000901	CcSEcCtD
Amitriptyline—Paraesthesia—Epirubicin—pancreatic cancer	6.03e-05	0.000896	CcSEcCtD
Amitriptyline—Hyperhidrosis—Doxorubicin—pancreatic cancer	6.01e-05	0.000893	CcSEcCtD
Amitriptyline—Somnolence—Epirubicin—pancreatic cancer	5.97e-05	0.000887	CcSEcCtD
Amitriptyline—Anorexia—Doxorubicin—pancreatic cancer	5.92e-05	0.00088	CcSEcCtD
Amitriptyline—Nausea—Docetaxel—pancreatic cancer	5.91e-05	0.000879	CcSEcCtD
Amitriptyline—Dyspepsia—Epirubicin—pancreatic cancer	5.91e-05	0.000879	CcSEcCtD
Amitriptyline—Decreased appetite—Epirubicin—pancreatic cancer	5.84e-05	0.000868	CcSEcCtD
Amitriptyline—Hypotension—Doxorubicin—pancreatic cancer	5.81e-05	0.000863	CcSEcCtD
Amitriptyline—Fatigue—Epirubicin—pancreatic cancer	5.79e-05	0.000861	CcSEcCtD
Amitriptyline—Constipation—Epirubicin—pancreatic cancer	5.74e-05	0.000854	CcSEcCtD
Amitriptyline—Insomnia—Doxorubicin—pancreatic cancer	5.62e-05	0.000835	CcSEcCtD
Amitriptyline—Paraesthesia—Doxorubicin—pancreatic cancer	5.58e-05	0.000829	CcSEcCtD
Amitriptyline—Feeling abnormal—Epirubicin—pancreatic cancer	5.53e-05	0.000823	CcSEcCtD
Amitriptyline—Somnolence—Doxorubicin—pancreatic cancer	5.52e-05	0.000821	CcSEcCtD
Amitriptyline—Dyspepsia—Doxorubicin—pancreatic cancer	5.47e-05	0.000813	CcSEcCtD
Amitriptyline—Decreased appetite—Doxorubicin—pancreatic cancer	5.4e-05	0.000803	CcSEcCtD
Amitriptyline—Fatigue—Doxorubicin—pancreatic cancer	5.36e-05	0.000796	CcSEcCtD
Amitriptyline—Urticaria—Epirubicin—pancreatic cancer	5.33e-05	0.000793	CcSEcCtD
Amitriptyline—Constipation—Doxorubicin—pancreatic cancer	5.31e-05	0.00079	CcSEcCtD
Amitriptyline—Body temperature increased—Epirubicin—pancreatic cancer	5.31e-05	0.000789	CcSEcCtD
Amitriptyline—Feeling abnormal—Doxorubicin—pancreatic cancer	5.12e-05	0.000761	CcSEcCtD
Amitriptyline—Urticaria—Doxorubicin—pancreatic cancer	4.94e-05	0.000734	CcSEcCtD
Amitriptyline—Body temperature increased—Doxorubicin—pancreatic cancer	4.91e-05	0.00073	CcSEcCtD
Amitriptyline—Asthenia—Epirubicin—pancreatic cancer	4.82e-05	0.000716	CcSEcCtD
Amitriptyline—Pruritus—Epirubicin—pancreatic cancer	4.75e-05	0.000706	CcSEcCtD
Amitriptyline—Diarrhoea—Epirubicin—pancreatic cancer	4.59e-05	0.000683	CcSEcCtD
Amitriptyline—Asthenia—Doxorubicin—pancreatic cancer	4.46e-05	0.000663	CcSEcCtD
Amitriptyline—Dizziness—Epirubicin—pancreatic cancer	4.44e-05	0.00066	CcSEcCtD
Amitriptyline—Pruritus—Doxorubicin—pancreatic cancer	4.4e-05	0.000653	CcSEcCtD
Amitriptyline—Vomiting—Epirubicin—pancreatic cancer	4.27e-05	0.000635	CcSEcCtD
Amitriptyline—Diarrhoea—Doxorubicin—pancreatic cancer	4.25e-05	0.000632	CcSEcCtD
Amitriptyline—Rash—Epirubicin—pancreatic cancer	4.23e-05	0.000629	CcSEcCtD
Amitriptyline—Dermatitis—Epirubicin—pancreatic cancer	4.23e-05	0.000629	CcSEcCtD
Amitriptyline—Headache—Epirubicin—pancreatic cancer	4.21e-05	0.000625	CcSEcCtD
Amitriptyline—Dizziness—Doxorubicin—pancreatic cancer	4.11e-05	0.000611	CcSEcCtD
Amitriptyline—Nausea—Epirubicin—pancreatic cancer	3.99e-05	0.000593	CcSEcCtD
Amitriptyline—Vomiting—Doxorubicin—pancreatic cancer	3.95e-05	0.000587	CcSEcCtD
Amitriptyline—Rash—Doxorubicin—pancreatic cancer	3.92e-05	0.000582	CcSEcCtD
Amitriptyline—Dermatitis—Doxorubicin—pancreatic cancer	3.91e-05	0.000582	CcSEcCtD
Amitriptyline—Headache—Doxorubicin—pancreatic cancer	3.89e-05	0.000579	CcSEcCtD
Amitriptyline—Nausea—Doxorubicin—pancreatic cancer	3.69e-05	0.000549	CcSEcCtD
Amitriptyline—ADRA1D—Signaling Pathways—KRAS—pancreatic cancer	1.48e-06	1.38e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—HRAS—pancreatic cancer	1.48e-06	1.38e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	1.47e-06	1.37e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	1.47e-06	1.37e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—PTEN—pancreatic cancer	1.47e-06	1.37e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	1.47e-06	1.37e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—HRAS—pancreatic cancer	1.47e-06	1.37e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CXCL8—pancreatic cancer	1.47e-06	1.37e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	1.46e-06	1.36e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—TP53—pancreatic cancer	1.46e-06	1.36e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MMP9—pancreatic cancer	1.46e-06	1.36e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	1.46e-06	1.36e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—APOE—pancreatic cancer	1.46e-06	1.36e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	1.45e-06	1.36e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MMP9—pancreatic cancer	1.45e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	1.45e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—PTEN—pancreatic cancer	1.45e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	1.45e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PTEN—pancreatic cancer	1.45e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PIK3CD—pancreatic cancer	1.45e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—PTEN—pancreatic cancer	1.45e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	1.44e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PTEN—pancreatic cancer	1.44e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—PIK3CA—pancreatic cancer	1.44e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—VEGFA—pancreatic cancer	1.44e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	1.44e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PIK3CB—pancreatic cancer	1.44e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—HRAS—pancreatic cancer	1.44e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	1.44e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	1.44e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PTGS2—pancreatic cancer	1.43e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	1.43e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—STAT3—pancreatic cancer	1.43e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	1.43e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PTGS2—pancreatic cancer	1.43e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—NRAS—pancreatic cancer	1.42e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	1.42e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	1.42e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	1.42e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—AKT1—pancreatic cancer	1.41e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	1.41e-06	1.31e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	1.41e-06	1.31e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	1.4e-06	1.31e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	1.4e-06	1.31e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—TP53—pancreatic cancer	1.4e-06	1.3e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—HRAS—pancreatic cancer	1.39e-06	1.3e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MYC—pancreatic cancer	1.39e-06	1.3e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	1.39e-06	1.3e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	1.39e-06	1.29e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MYC—pancreatic cancer	1.39e-06	1.29e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	1.38e-06	1.29e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TGFB1—pancreatic cancer	1.38e-06	1.29e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.38e-06	1.29e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.38e-06	1.28e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—PIK3CA—pancreatic cancer	1.37e-06	1.28e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	1.37e-06	1.27e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—SRC—pancreatic cancer	1.36e-06	1.27e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	1.36e-06	1.27e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	1.36e-06	1.27e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—PIK3CA—pancreatic cancer	1.36e-06	1.26e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—PIK3CA—pancreatic cancer	1.36e-06	1.26e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—EGFR—pancreatic cancer	1.36e-06	1.26e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	1.35e-06	1.26e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	1.35e-06	1.26e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—SRC—pancreatic cancer	1.34e-06	1.25e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—SRC—pancreatic cancer	1.34e-06	1.25e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—SRC—pancreatic cancer	1.34e-06	1.25e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—HRAS—pancreatic cancer	1.34e-06	1.24e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—SRC—pancreatic cancer	1.33e-06	1.24e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	1.33e-06	1.24e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MYC—pancreatic cancer	1.33e-06	1.24e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—TP53—pancreatic cancer	1.33e-06	1.24e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	1.33e-06	1.24e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—AKT1—pancreatic cancer	1.32e-06	1.23e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TGFB1—pancreatic cancer	1.32e-06	1.23e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—SRC—pancreatic cancer	1.32e-06	1.23e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	1.32e-06	1.23e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—STAT3—pancreatic cancer	1.32e-06	1.23e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	1.32e-06	1.23e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	1.31e-06	1.22e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—NRAS—pancreatic cancer	1.31e-06	1.22e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—TP53—pancreatic cancer	1.31e-06	1.22e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—TP53—pancreatic cancer	1.31e-06	1.22e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—VEGFA—pancreatic cancer	1.31e-06	1.22e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	1.31e-06	1.22e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—AKT1—pancreatic cancer	1.31e-06	1.22e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—AKT1—pancreatic cancer	1.3e-06	1.22e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	1.3e-06	1.21e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—EGFR—pancreatic cancer	1.3e-06	1.21e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	1.3e-06	1.21e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—STAT3—pancreatic cancer	1.3e-06	1.21e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—AKT1—pancreatic cancer	1.3e-06	1.21e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—STAT3—pancreatic cancer	1.29e-06	1.2e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—NRAS—pancreatic cancer	1.29e-06	1.2e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	1.29e-06	1.2e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—NRAS—pancreatic cancer	1.29e-06	1.2e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	1.29e-06	1.2e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	1.29e-06	1.2e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	1.29e-06	1.2e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	1.29e-06	1.2e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	1.28e-06	1.2e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	1.28e-06	1.2e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	1.28e-06	1.19e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	1.28e-06	1.19e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—KRAS—pancreatic cancer	1.28e-06	1.19e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PTGS2—pancreatic cancer	1.28e-06	1.19e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	1.27e-06	1.19e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	1.27e-06	1.18e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—AKT1—pancreatic cancer	1.27e-06	1.18e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	1.27e-06	1.18e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PPARG—pancreatic cancer	1.27e-06	1.18e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—HRAS—pancreatic cancer	1.27e-06	1.18e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	1.27e-06	1.18e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PIK3CB—pancreatic cancer	1.26e-06	1.18e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—HRAS—pancreatic cancer	1.26e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—HRAS—pancreatic cancer	1.26e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PTEN—pancreatic cancer	1.25e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PTGS2—pancreatic cancer	1.25e-06	1.16e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PTEN—pancreatic cancer	1.24e-06	1.16e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—AKT1—pancreatic cancer	1.23e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—KRAS—pancreatic cancer	1.23e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MYC—pancreatic cancer	1.22e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	1.22e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	1.22e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—PIK3CA—pancreatic cancer	1.21e-06	1.13e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MYC—pancreatic cancer	1.2e-06	1.12e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MYC—pancreatic cancer	1.2e-06	1.12e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TGFB1—pancreatic cancer	1.2e-06	1.12e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	1.2e-06	1.12e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MYC—pancreatic cancer	1.2e-06	1.12e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—EGFR—pancreatic cancer	1.2e-06	1.12e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	1.19e-06	1.11e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MYC—pancreatic cancer	1.19e-06	1.11e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	1.19e-06	1.11e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	1.19e-06	1.11e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	1.19e-06	1.11e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	1.18e-06	1.1e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MYC—pancreatic cancer	1.18e-06	1.1e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—AKT1—pancreatic cancer	1.18e-06	1.1e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	1.18e-06	1.1e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	1.18e-06	1.1e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	1.18e-06	1.1e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	1.18e-06	1.1e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PTGS2—pancreatic cancer	1.18e-06	1.1e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—EGFR—pancreatic cancer	1.18e-06	1.1e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—PIK3CA—pancreatic cancer	1.18e-06	1.1e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	1.18e-06	1.1e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	1.18e-06	1.1e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—EGFR—pancreatic cancer	1.17e-06	1.09e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	1.17e-06	1.09e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PTGS2—pancreatic cancer	1.17e-06	1.09e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	1.17e-06	1.09e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	1.16e-06	1.08e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	1.15e-06	1.08e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	1.15e-06	1.07e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TP53—pancreatic cancer	1.14e-06	1.07e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TP53—pancreatic cancer	1.14e-06	1.06e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—KRAS—pancreatic cancer	1.13e-06	1.05e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—PIK3CA—pancreatic cancer	1.13e-06	1.05e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—APOE—pancreatic cancer	1.12e-06	1.05e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—AKT1—pancreatic cancer	1.12e-06	1.04e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PTEN—pancreatic cancer	1.12e-06	1.04e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—KRAS—pancreatic cancer	1.11e-06	1.04e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	1.11e-06	1.04e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—KRAS—pancreatic cancer	1.11e-06	1.03e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—AKT1—pancreatic cancer	1.11e-06	1.03e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—AKT1—pancreatic cancer	1.11e-06	1.03e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	1.11e-06	1.03e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	1.1e-06	1.03e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	1.09e-06	1.02e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	1.09e-06	1.02e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	1.09e-06	1.02e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	1.09e-06	1.02e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PTEN—pancreatic cancer	1.09e-06	1.02e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TP53—pancreatic cancer	1.09e-06	1.02e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	1.09e-06	1.01e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—HRAS—pancreatic cancer	1.09e-06	1.01e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	1.07e-06	9.98e-06	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	1.04e-06	9.71e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—HRAS—pancreatic cancer	1.04e-06	9.71e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	1.04e-06	9.68e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PTEN—pancreatic cancer	1.03e-06	9.57e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—PIK3CA—pancreatic cancer	1.02e-06	9.52e-06	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	1.02e-06	9.51e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	1.02e-06	9.5e-06	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	1.02e-06	9.49e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PTEN—pancreatic cancer	1.02e-06	9.49e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	1.02e-06	9.47e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.01e-06	9.45e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	1.01e-06	9.44e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	1.01e-06	9.43e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	1.01e-06	9.38e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TP53—pancreatic cancer	1e-06	9.36e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	1e-06	9.35e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	1e-06	9.32e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PTGS2—pancreatic cancer	9.97e-07	9.3e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—AKT1—pancreatic cancer	9.9e-07	9.22e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TP53—pancreatic cancer	9.88e-07	9.21e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TP53—pancreatic cancer	9.86e-07	9.19e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TP53—pancreatic cancer	9.83e-07	9.16e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TP53—pancreatic cancer	9.8e-07	9.13e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PPARG—pancreatic cancer	9.79e-07	9.12e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TP53—pancreatic cancer	9.7e-07	9.04e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	9.68e-07	9.02e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	9.66e-07	9e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—AKT1—pancreatic cancer	9.61e-07	8.96e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—HRAS—pancreatic cancer	9.61e-07	8.95e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—HRAS—pancreatic cancer	9.45e-07	8.81e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—HRAS—pancreatic cancer	9.43e-07	8.79e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	9.4e-07	8.76e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	9.37e-07	8.73e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	9.29e-07	8.66e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	9.28e-07	8.65e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	9.26e-07	8.63e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—AKT1—pancreatic cancer	9.2e-07	8.57e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—AKT1—pancreatic cancer	9.08e-07	8.46e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	8.99e-07	8.38e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	8.91e-07	8.31e-06	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	8.82e-07	8.22e-06	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PIK3CA—pancreatic cancer	8.77e-07	8.18e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PTEN—pancreatic cancer	8.7e-07	8.11e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	8.6e-07	8.01e-06	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—AKT1—pancreatic cancer	8.51e-07	7.93e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—AKT1—pancreatic cancer	8.48e-07	7.91e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—AKT1—pancreatic cancer	8.35e-07	7.78e-06	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—AKT1—pancreatic cancer	8.34e-07	7.77e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—AKT1—pancreatic cancer	8.33e-07	7.76e-06	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—AKT1—pancreatic cancer	8.32e-07	7.76e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	8.3e-07	7.74e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	8.27e-07	7.71e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	8.19e-07	7.64e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	8.17e-07	7.62e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	7.88e-07	7.34e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	7.77e-07	7.24e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PTGS2—pancreatic cancer	7.7e-07	7.17e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PIK3CA—pancreatic cancer	7.69e-07	7.16e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	7.59e-07	7.08e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	7.24e-07	6.75e-06	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—AKT1—pancreatic cancer	7.21e-07	6.72e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	7.18e-07	6.69e-06	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—AKT1—pancreatic cancer	7.17e-07	6.68e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PTEN—pancreatic cancer	6.71e-07	6.26e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—AKT1—pancreatic cancer	6.43e-07	6e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—AKT1—pancreatic cancer	6.28e-07	5.85e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	6.14e-07	5.72e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—AKT1—pancreatic cancer	5.92e-07	5.52e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—AKT1—pancreatic cancer	5.87e-07	5.47e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—AKT1—pancreatic cancer	5.01e-07	4.67e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	4.74e-07	4.41e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—AKT1—pancreatic cancer	3.87e-07	3.61e-06	CbGpPWpGaD
